The National Development and Reform Commission (NDRC) has formally launched a nationwide pricing investigation into China's pharmaceutical and medical devices industries.
Drug pricing probes pressure companies
China's antitrust regulator has launched an official investigation campaign to unravel the complex supply and distribution networks of drugs and medical devices. Healthcare firms will need to ensure proper pricing conduct and prepare for the surveys and raids
By
Katherine Jo and clp articles